Hitna potreba za otkrivanjem bubrežne bolesti kod osoba sa dijabetesom

Diabetes study

File photo dated 03/10/14 of a nurse giving a patient a diabetes test. More information is needed on a weight-loss jab's effectiveness in treating type 2 diabetes before it is recommended for NHS use, the National Institute for Health and Care Excellence (Nice) has said.Issue date: Tuesday June 27, 2023.. The recommendation for tirzepatide, which is sold under the brand name Mounjaro and is developed by Eli Lilly, was issued in draft guidance issued by the public body. See PA story HEALTH Type2Diabetes. Photo credit should read: Peter Byrne/PA Wire Credit: Peter Byrne/PA/Alamy

Postoji hitna potreba za programom skeniranja bubrega kod osoba koje žive s dijabetesom jer se čekuje da će se do 2045. godine u Australiji udvostručiti broj ljudi koji žive s dijabetesom, na oko tri miliona. Dijabetes može dovesti do ozbiljnog oboljenja bubrega, ili njihovog zatajenja, a koje se može spriječiti.



Share